Loading organizations...
§ Venture Capital · Wilmington, DE, USA
MC Life Sciences Ventures operates as a venture capital firm, specializing in strategic investments across the life science and biopharmaceutical sectors. Headquartered in New York, NY, the firm supports innovative companies developing novel therapeutics and biotechnologies. It provides capital to accelerate research, development, and market entry, advancing global healthcare.
Established in 1954, MC Life Sciences Ventures was an investment arm of Mitsubishi International Corporation (MIC), reflecting Mitsubishi Corporation’s strategic interest in diverse industrial sectors. This dedicated unit was formed to directly engage with and foster emerging scientific innovations, leveraging Mitsubishi's resources and network to seize high-potential biotechnology opportunities.
The firm invested primarily in early to growth-stage life science and biopharmaceutical companies, offering financial backing and strategic guidance. MC Life Sciences Ventures partnered with these companies to translate scientific discoveries into viable commercial products. Its vision was to drive human health progress by nurturing scientific enterprises within the life science ecosystem.
MC Life Science Ventures has 1 tracked investment across 1 company. The latest tracked deal is $6.0M Other Equity in Syndax Pharmaceuticals in August 2010.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 15, 2010 | Syndax Pharmaceuticals | $6.0M Other Equity | — | Avalon Ventures, Domain Associates, Forward Ventures, MPM Capital, Pappas Ventures |